Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Rapid Micro Biosystems ( (RPID) ) has provided an update.
On May 22, 2025, Jeffrey Schwartz resigned from the board of directors of Rapid Micro Biosystems, where he served since April 2018, without any disagreements with the company. During the company’s annual meeting on the same day, stockholders elected Dafni Bika and Inese Lowenstein as Class I Directors and ratified PricewaterhouseCoopers LLP as the independent auditor for the fiscal year ending December 31, 2025.
The most recent analyst rating on (RPID) stock is a Buy with a $8.00 price target. To see the full list of analyst forecasts on Rapid Micro Biosystems stock, see the RPID Stock Forecast page.
Spark’s Take on RPID Stock
According to Spark, TipRanks’ AI Analyst, RPID is a Neutral.
Rapid Micro Biosystems has strong revenue growth and positive technical momentum, but faces significant challenges in profitability and cash flow. The strategic partnerships and improved guidance offer potential upside, yet the negative valuation metrics reflect current financial struggles. The stock is positioned for growth, yet investors should be cautious of underlying financial weaknesses.
To see Spark’s full report on RPID stock, click here.
More about Rapid Micro Biosystems
Rapid Micro Biosystems operates in the biotechnology industry, focusing on providing innovative solutions for the rapid detection of microbial contamination in the manufacturing process.
Average Trading Volume: 379,551
Technical Sentiment Signal: Buy
Current Market Cap: $138.1M
Find detailed analytics on RPID stock on TipRanks’ Stock Analysis page.